Evidence map›Paper›PMID 26957858›Full record

ArticleMiddle East African journal of ophthalmology

Ocular Leishmaniasis Treated by Intralesional Amphotericin B.

Malihe Nikandish, Vahid Mashayekhi Goyonlo, Ahmad Reza Taheri, Bita Kiafar

Abstract readCase Reports
In one paragraph

Article in Middle East African journal of ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
1.0field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 13 citations in OpenAlex.

  1. Ocular Leishmaniasis - A systematic review.Indian journal of ophthalmology · 2021
    Pooled it
  2. Pooled it
  3. Unusual Observations in Leishmaniasis-An Overview.Pathogens (Basel, Switzerland) · 2023
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Intralesional Agents in Dermatology: Pros and Cons.Journal of cutaneous and aesthetic surgery
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Malihe NikandishCornea Research Center, Cornea and Anterior Segment Fellowship, Khatam-al-Anbia Eye Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.
Vahid Mashayekhi GoyonloCutaneous Leishmaniasis Research Center, School of Medicine, Emam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.
Ahmad Reza TaheriCutaneous Leishmaniasis Research Center, School of Medicine, Emam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.
Bita KiafarCutaneous Leishmaniasis Research Center, School of Medicine, Emam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.
Emam Reza Hospital · IRKhatam University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leishmaniasis is a group of diseases with varied clinical manifestations. Ocular involvement is an unusual presentation of leishmaniasis, and the eyelid is not a common site of cutaneous lesions, likely due to the mobility of the lids. Some case reports of conjunctival involvement are either a contiguous dissemination from lid margin or in the setting of disseminated leishmaniasis in an immunocompromised host. To our knowledge, isolated involvement of the bulbar conjunctiva has not been reported. We present the first case in the literature of a patient with an erythematous fibrovascular lesion in the interpalpebral zone that was clinically diagnosed as pterygium, but recurred at the site of surgical excision. After histopathologic diagnosis, the lesion was treated with intralesional injection of amphotericin B and improved completely within a few weeks. An accurate diagnosis of leishmaniasis in the eye may be challenging in many clinical settings. To our knowledge, an isolated pterygium.like lesion has not been reported in literature. In addition, intralesional injection of amphotericin B is a novel treatment method in this setting.

Indexed as

Amphotericin BAntiprotozoal AgentsConjunctival DiseasesEye Infections, ParasiticFemaleHumansImmunocompromised HostInjections, IntralesionalLeishmania majorLeishmaniasis, CutaneousMiddle AgedAmphotericin BAntiprotozoal AgentsConjunctivaeIntralesional Amphotericin BOcular Leishmaniasis

Identifiers

PMID26957858
PMCPMC4759897
OpenAlexW2301182535

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.